Search results
Showing 3346 to 3360 of 8932 results
This indicator covers the percentage of patients with diabetes, on the register, with a diagnosis of nephropathy (clinical proteinuria) or micro-albuminuria who are currently treated with an ACE-I (or ARBs). It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM95.
The complete list of all our published indicators, for measuring outcomes that reflect the quality of care or processes, linked by evidence to improved outcomes.
Home Implementing NICE guidance...
Home Implementing NICE guidance Social care...
Home About us Executive team...
Download (PDF) Treatment pathways We have produced treatment pathways bringing together NICE
These are the main stages in the multiple technology appraisal process used before April 2018.
The key stages in development of our quality standards
Agenda and papers of the NICE public board meeting on 16 December 2022
Appraisal is the process of determining which records have continuing business or historical value from those which have no further value and should be disposed of appropriately.
Following the government’s 10 Year Health Plan for England, we're strengthening our role in getting the best healthtech, including digital tools, diagnostics and medical devices, to patients.
People and communities - putting you at the heart of our work
NICE is committed to involving people who use services, carers and the public in the development of our guidance and other products.
Our methods and processes (health technology evaluation manual)
NICE's technology appraisal and highly specialised technologies guidance manual
Our content assurance service. Includes what the service offers, how to apply and pricing.
Learn more about what NICE content is available for reuse by checking our information asset register.